The European Society of Medical Oncology (ESMO) has recently published updated guidelines for cutaneous melanoma, replacing the previous (2019) guidelines. The Clinical Practice Guideline provides diagnosis, staging, risk assessment, treatment and follow-up recommendations for cutaneous melanoma. Algorithms for diagnosis, staging, management (stages I-IV and melanoma brain metastases) and follow-up are provided.

ESMO Clinical Practice Guideline

Source:

T. Amaral, M. Ottaviano, A. Arance, C. Blank, V. Chiarion-Sileni, M. Donia, R. Dummer, C. Garbe, J.E. Gershenwald, H. Gogas, M. Guckenberger, J. Haanen, O. Hamid, A. Hauschild, C. Höller, C. Lebbé, R.J. Lee, G.V. Long, P. Lorigan, E. Muñoz Couselo, P. Nathan, C. Robert, E. Romano, D. Schadendorf, V. Sondak, K.P.M. Suijkerbuijk, A.C.J. van Akkooi, O. Michielin, P.A. Ascierto, Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆,
Annals of Oncology, Volume 36, Issue 1, 2025, Pages 10-30, ISSN 0923-7534, https://doi.org/10.1016/j.annonc.2024.11.006.

https://www.annalsofoncology.org/article/S0923-7534(24)04912-3/fulltext